当前位置:首页 - 行情中心 - 明德生物(002932) - 财务分析 - 利润表

明德生物

(002932)

69.44

6.31  (10.00%)

今开:69.44最高:69.44成交:0.10万手 市盈:0.00 上证指数:2839.83   0.37%2018-07-23
昨收:63.13 最低:69.44 换手:0.00%振幅:0.00 深证指数:9237.05  -0.16%11:30:00

集合

竞价

利润表

按照会计年度查询:
报告期2018-03-312017-12-312017-06-302017-03-31
一、营业总收入37,824,801.9165,123,343.783,930,799.630,485,800
营业收入37,824,801.9165,123,343.783,930,799.630,485,800
二、营业总成本21,528,420.2296,784,209.8344,528,216.980
营业成本8,283,610.3229,950,555.413,983,772.88--
营业税金及附加368,929.291,450,714.1725,163.36--
销售费用5,458,828.2328,762,409.1412,935,564.91--
管理费用7,359,737.5236,695,507.0716,707,536.34--
财务费用-166,179.78-558,580.25-316,441.98--
资产减值损失223,494.64483,604.37492,621.47--
三、其他经营收益--------
允许价值变动净收益--------
投资净收益--1,453,452.07573,178.09--
联营、合营企业投资收益--------
汇兑净收益--------
四、营业利润16,404,338.3975,663,752.1539,975,760.7112,829,700
营业外收入--500,0001,027,895.9--
营业外支出--737,918.26673,282.49--
非流动资产处置净损失--------
五、利润总额16,404,338.3975,425,833.8940,330,374.1212,965,400
所得税2,507,383.359,872,017.176,191,251.68--
未确认的投资损失--------
六、净利润(百万元)13.6265.4934.1310.95
少数股东损益274,228.5661,169.475,233.6--
归属于母公司股东的净利润13,622,726.4865,492,647.2534,133,888.8410,954,000
七、每股收益0.271.310.68--
基本每股收益0.271.310.68--
稀释每股收益0.271.310.68--
TOP↑